ReviewBiodesign research2026
From machine learning to multimodal models: The AI revolution in enzyme engineering.
Review in Biodesign research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence and automation in enzyme engineering: evolution, advances, and future perspectives.Bioresources and bioprocessing · 2026Review
- AI-Driven Enzyme Engineering: Emerging Models and Next-Generation Biotechnological Applications.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein engineering is a powerful tool for applications spanning synthetic biology, biocatalysis, and drug discovery. Recent advances in artificial intelligence (AI), from conventional machine learning (ML) algorithms to large-scale pre-trained protein models, have greatly accelerated enzyme engineering field entering a data-driven era. This review provides a guidance map of current enzyme engineering tasks and builds an integrative perspective on AI methods, model types, landmark tasks, and data resources. We begin by delineating the core modeling tasks in enzyme engineering, which include encompassing function annotation, structural modeling, and property prediction and by reviewing recent advances alongside dominant algorithmic frameworks. Next, we outlined the evolution of AI into enzyme engineering, tracing its progression through four stages: classical machine learning approaches, deep neural networks, protein language models (pLMs), and emerging multimodal architectures. Finally, we highlight four trends that are redefining the landscape of AI-driven enzyme design: (i) the replacement of handcrafted features with unified, token-level embeddings; (ii) a shift from single-modal models toward multimodal, multitask systems; (iii) the emergence of intelligent agents capable of reasoning; and (iv) a movement beyond static structure prediction toward dynamic simulation of enzyme function. Together, these developments are paving the way for intelligent, generalizable, and mechanistically interpretable AI platforms poised to synthetic biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.